MT-4666

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MT-4666, covering 2015-09-28 to 2015-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of MT-4666 in Subjects With Alzheimer's Disease [Phase 3]